Impaired Vigilance, and Its Effects on Cognition and Behavior

June 29, 2015 updated by: Jamie M. Zeitzer, Ph.D., Stanford University
Fifty healthy, young participants (10 male, 40 female) completed two 3-hour study sessions that were at least five days apart. The first session was a baseline. The sleep intervention took place on the night prior to Session 2, where the amount of time in bed was manipulated to be 60-130% of the individual's habitual sleep time. Within both sessions, subjective (Stanford Sleepiness Scale, SSS) and objective (Psychomotor Vigilance Test, PVT) alertness were measured. During the middle of each session, a 40-minute ad libitum meal opportunity allowed participants to eat from eight different food items. Food healthfulness, caloric density, distribution and number of calories were measured and compared to alertness levels.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: 18-45 years
  • BMI: 20-29 kg/m²
  • Eat breakfast at least 5 days per week
  • Wake time occurs between 5&10AM at least 5 days per week
  • Time in bed for sleep between 5&10 hours at least 5 days per week

Exclusion Criteria:

  • Dietary restrictions that prohibit them from selecting one of the food choices offered in the study (e.g., gluten allergies, diabetes, vegan diet, dairy avoidance, allergies to the respective food choices available),
  • are currently on a calorie-restricted diet, or
  • are currently at a weight that is less than 20% of their highest weight within the last three years.
  • Participation in shift work within 7 nights of the experiment
  • Diagnosed as having severe sleep apnea syndrome, narcolepsy or chronic insomnia
  • Diagnosed as having an eating disorder
  • Active serious health condition
  • Regularly taking vigilance-related medication (e.g., ADHD prescribed medication)
  • Typically consume more than 600 mg of coffee or more than 10 cigarettes per day

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 60% TIB
Participants were to spend 60% of their normal time in bed on the night prior to the second visit.
Habitual time spent in bed for the purpose of sleep was determined at baseline. This was used to calculated the experimental time in bed the subject was to spent on the one night prior to the second lab visit.
Experimental: 70% TIB
Participants were to spend 70% of their normal time in bed on the night prior to the second visit.
Habitual time spent in bed for the purpose of sleep was determined at baseline. This was used to calculated the experimental time in bed the subject was to spent on the one night prior to the second lab visit.
Experimental: 80% TIB
Participants were to spend 80% of their normal time in bed on the night prior to the second visit.
Habitual time spent in bed for the purpose of sleep was determined at baseline. This was used to calculated the experimental time in bed the subject was to spent on the one night prior to the second lab visit.
Experimental: 90% TIB
Participants were to spend 90% of their normal time in bed on the night prior to the second visit.
Habitual time spent in bed for the purpose of sleep was determined at baseline. This was used to calculated the experimental time in bed the subject was to spent on the one night prior to the second lab visit.
Active Comparator: 100% TIB
Participants were to spend 100% of their normal time in bed (i.e., no change) on the night prior to the second visit.
Habitual time spent in bed for the purpose of sleep was determined at baseline. This was used to calculated the experimental time in bed the subject was to spent on the one night prior to the second lab visit.
Experimental: 115% TIB
Participants were to spend 115% of their normal time in bed on the night prior to the second visit.
Habitual time spent in bed for the purpose of sleep was determined at baseline. This was used to calculated the experimental time in bed the subject was to spent on the one night prior to the second lab visit.
Experimental: 130% TIB
Participants were to spend 130% of their normal time in bed on the night prior to the second visit.
Habitual time spent in bed for the purpose of sleep was determined at baseline. This was used to calculated the experimental time in bed the subject was to spent on the one night prior to the second lab visit.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total calories consumed
Time Frame: 45 minutes
Total calories consumed during a 45 minute meal opportunity during the each of the two study sessions.
45 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alertness
Time Frame: 15 minutes
Objective alertness was determined during each of the two study sessions during a 15 minute test of sustained attention (Psychomotor Vigilance Task).
15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

March 1, 2012

Study Completion (Actual)

March 1, 2012

Study Registration Dates

First Submitted

June 24, 2015

First Submitted That Met QC Criteria

June 29, 2015

First Posted (Estimate)

June 30, 2015

Study Record Updates

Last Update Posted (Estimate)

June 30, 2015

Last Update Submitted That Met QC Criteria

June 29, 2015

Last Verified

June 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Deprivation

Clinical Trials on Time in bed

Subscribe